Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination

類似資料

• Neurofascin-155 as a putative antigen in combined central and peripheral demyelination
  著者:: Cortese, Andrea, 等
  出版事項: (2016)
• Central and peripheral demyelination
  著者:: Mehndiratta, Man Mohan, 等
  出版事項: (2014)
• Combined central and peripheral demyelination
  著者:: Menon, Bindu, 等
  出版事項: (2014)
• HCV-Related Central and Peripheral Nervous System Demyelinating Disorders
  著者:: Mariotto, Sara, 等
  出版事項: (2014)
• Remarkable Rituximab Response on Tremor Related to Acute‐Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy in an Antineurofascin155 Immunoglobulin G4–Seropositive Patient
  著者:: Demichelis, Chiara, 等
  出版事項: (2018)